...Inc. (NASDAQ:ARNA) appointed Garry Neil as chair and Nawal Ouzren as a board member. Neil is CSO at Cerecor Inc....

...where he was SVP of business development; Calias was CSO and head of R&D at Cerecor Inc....

...succeeded in the role by Joe Miller, who was CFO and principal executive officer of Cerecor Inc....

...at the cancer antibody company on an interim basis. Rare pediatric and orphan disease company Cerecor Inc....
...BioCentury Staff Ultragenyx Pharmaceutical Inc. Axsome Therapeutics Inc. ElevateBio LLC Satsuma Pharmaceuticals Inc. WindMIL Therapeutics Inc. Anika Therapeutics Inc. Prothena Corp. plc MacroGenics Inc. Cerecor Inc. PsiOxus...

...and CEO, will remain an adviser for the next 12 months. Greenleaf was CEO of Cerecor Inc....

...hired John Kaiser as interim chairman and CEO. He was interim CEO and CBO at Cerecor Inc....

...Neurology play Cerecor Inc. (NASDAQ:CERC) said CFO Mariam Morris is stepping down. She is succeeded by Joe...
...who was VP of finance at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Additionally, Cerecor...

...Neurology play Cerecor Inc. (NASDAQ:CERC) acquired therapeutic company TRx Pharmaceuticals LLC for $23 million, comprising $18.9 million...
...Pharmaceuticals LLC for $23 million, comprising $18.9 million in cash and $4.1 million in stock. Cerecor...
...in milestones. Cerecor Inc. (NASDAQ:CERC), Baltimore, Md. TRx Pharmaceuticals LLC, Chapel Hill, N.C. Business: Neurology Elizabeth S. Eaton Cerecor Inc. TRx...

...Cerecor exclusive, worldwide rights to develop and commercialize CERC-501 (see BioCentury March 9, 2015 ). Cerecor's...
...treat MDD. Cerecor Inc. (NASDAQ:CERC), Baltimore, Md. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Neurology Shannon Lehnbeuter CERC-501 Cerecor Inc. Eli...

...Neurology play Cerecor Inc. (NASDAQ:CERC) said Uli Hacksell retired as president and CEO. CBO John Kaiser will...